Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News OS Therapies Inc OSTX

Healthcare Biotechnology
OS Therapies Incorporated is a clinical-stage biopharmaceutical company. The Company is focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. It built a pipeline of product candidates targeting multiple indications for solid cancers. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. OST-HER2 is an off-the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSEAM:OSTX)

OS Therapies Announces Phase 2b Clinical Trial of OST-HER2 Achieves Primary Endpoint with Statistical Significance in the Prevention of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma

Business Wire 7 days ago

OS Therapies to Attend the 43rd Annual J.P. Morgan Healthcare Conference

Business Wire January 2, 2025

OS Therapies Announces Closing of $6 Million Private Placement

Business Wire December 31, 2024

OS Therapies Partners with B2i Digital to Engage with Biotech Investors Online

Business Wire December 26, 2024

OS Therapies Announces Pricing of $6 Million Private Placement

Business Wire December 24, 2024

OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

Business Wire November 15, 2024

OS Therapies to Present at The Spartan Capital Investor Conference

Business Wire November 4, 2024

Join OS Therapies' Exclusive Live Investor Webinar and Q&A Session on October 30

Business Wire October 30, 2024

OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors

Business Wire October 28, 2024
View More News ››

Opinion & Analysis (NYSEAM:OSTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSEAM:OSTX)

Buy buddy buy because it's taking off this morning.

It's time for you guys out there to be getting on board with this stock because it will be going up today,so good luck to all of you...
coolfooldumbguy - 7 days ago

Investors Beware: The Fed, Trump, and the Volatility

Investors Beware: The Fed, Trump, and the Volatility That Could Rock Your Portfolio (NYSE-A: OSTX) https://10xalerts.com/investors...
Mathew177 - September 3, 2024

OS Therapies Pioneers Hope for Osteosarcoma Patients

OS Therapies Pioneers Hope for Osteosarcoma Patients (NYSE-A: OSTX) ...
Mathew177 - August 22, 2024

The Future of Medicine: Key Biotech Stocks to Watch

The Future of Medicine: Key Biotech Stocks to Watch ($OSTX , $CRBP , $PBYI , $ATNM ) ...
Mathew177 - August 21, 2024

Investment Opportunities in a Shifting Market (NYSE-A: OSTX)

Investment Opportunities in a Shifting Market: Rate Cuts and One Stock Pick (NYSE-A: OSTX) https://10xalerts.com/investment-opportunities...
Brice978 - August 16, 2024

A Potential Game-Changer for Osteosarcoma $OSTX

OSTX's OST-HER2: A Potential Game-Changer for Osteosarcoma (NYSE-A: OSTX) ...
ElliotGH - August 15, 2024
View more Bullboard ››

Mullen Group Ltd.

Mullen Group Ltd.

Mullen Group is one of North America's largest logistics providers with a network of independently operated businesses ...
View More »